Godrej Agrovet Ltd
NSE:GODREJAGRO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
484.85
865.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Godrej Agrovet Ltd
Godrej Agrovet Ltd
Total Liabilities & Equity
Godrej Agrovet Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Godrej Agrovet Ltd
NSE:GODREJAGRO
|
Total Liabilities & Equity
₹57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Sukhjit Starch and Chemicals Ltd
NSE:SUKHJITS
|
Total Liabilities & Equity
₹10.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GRM Overseas Ltd
NSE:GRMOVER
|
Total Liabilities & Equity
₹7.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kaveri Seed Company Ltd
NSE:KSCL
|
Total Liabilities & Equity
₹20.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bombay Super Hybrid Seeds Ltd
NSE:BSHSL
|
Total Liabilities & Equity
₹1.6B
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gujarat Ambuja Exports Ltd
NSE:GAEL
|
Total Liabilities & Equity
₹33.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Godrej Agrovet Ltd
Glance View
Godrej Agrovet Ltd. engages in the manufacturing and marketing of animal feeds. The company is headquartered in Mumbai, Maharashtra and currently employs 2,711 full-time employees. The company went IPO on 2017-10-16. The Company’s principal activities include manufacturing and marketing animal feed, crop protection and agricultural inputs, palm oil and allied products, poultry and processed food and milk and milk products. Its segments include Animal feed, Vegetable Oil, Crop Protection, Dairy, Poultry & processed food, Real estate, and Other Business Segment, which includes Seed Business, Energy Generation through Windmill and Cattle Breeding Businesses. Its animal feed business has a diverse portfolio, cattle, poultry, aqua and specialty feed. Its oil palm business includes a range of products, such as crude palm oil, crude palm kernel oil and palm kernel cake. Its crop protection product portfolio includes plant growth regulators, organic manures, bioimplants and crop protection chemicals. Its subsidiaries include Godvet Agrochem Limited, Astec LifeSciences Limited, Creamline Dairy Products Limited, and Godrej Tyson Foods Limited.
See Also
What is Godrej Agrovet Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
57B
INR
Based on the financial report for Sep 30, 2024, Godrej Agrovet Ltd's Total Liabilities & Equity amounts to 57B INR.
What is Godrej Agrovet Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
4%
Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Godrej Agrovet Ltd have been 3% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
